11AM Hour: Exclusive Interviews with the CEOs of Biogen, Novartis & Visa 9/9/26
Squawk on the Street
- Published
- September 9, 2026
- Duration
- 49:21
- Summary source
- description
- Last updated
- Sep 9, 2026
Discusses ai, investing.
Summary
Biogen CEO Christopher Viehbacher joins from the Wells Fargo Health Care Conference to discuss the company's drug pipeline and growth outlook. Then, Novartis CEO Vas Narasimhan joins after the company had its third drug trial setback in a week. Plus, we bring you an interview with the CEO of Visa after the company released new data around AI and shopping.…
Intelligent Report
Sign in to read teasers, or upgrade to Research Pro to commission intelligent report for this episode. Learn more →
Show notes
Biogen CEO Christopher Viehbacher joins from the Wells Fargo Health Care Conference to discuss the company's drug pipeline and growth outlook. Then, Novartis CEO Vas Narasimhan joins after the company had its third drug trial setback in a week. Plus, we bring you an interview with the CEO of Visa after the company released new data around AI and shopping. Squawk on the Street Disclaimer Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of
Themes
- ai
- investing